116 related articles for article (PubMed ID: 3215259)
21. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Epstein JI; Amin MB; Reuter VE; Humphrey PA
Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic studies of prostatic cancer.
Lundgren R
Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
[TBL] [Abstract][Full Text] [Related]
23. Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy.
Arista-Nasr J; Martinez-Benitez B; Bornstein-Quevedo L; Aguilar-Ayala E; Aleman-Sanchez CN; Ortiz-Bautista R
Int Braz J Urol; 2016; 42(2):247-52. PubMed ID: 27256178
[TBL] [Abstract][Full Text] [Related]
24. Enzyme activities in prostatic carcinoma related to Gleason grades.
Pretlow TG; Harris BE; Bradley EL; Bueschen AJ; Lloyd KL; Pretlow TP
Cancer Res; 1985 Jan; 45(1):442-6. PubMed ID: 3155494
[TBL] [Abstract][Full Text] [Related]
25. Prostatic carcinoma: histological and immunohistological factors affecting prognosis.
Cohen RJ; Glezerson G; Haffejee Z; Afrika D
Br J Urol; 1990 Oct; 66(4):405-10. PubMed ID: 2224434
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
Dattoli M; Wallner K; True L; Cash J; Sorace R
Cancer; 2003 Feb; 97(4):979-83. PubMed ID: 12569596
[TBL] [Abstract][Full Text] [Related]
27. Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions.
El Sharkawy SL; Abbas NF; Badawi MA; El Shaer MA
J Clin Pathol; 2006 Nov; 59(11):1171-4. PubMed ID: 16574721
[TBL] [Abstract][Full Text] [Related]
28. Inverted papillomas of the prostatic urethra.
Fine SW; Chan TY; Epstein JI
Am J Surg Pathol; 2006 Aug; 30(8):975-9. PubMed ID: 16861968
[TBL] [Abstract][Full Text] [Related]
29. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
Epstein JI; Walsh PC; Brendler CB
J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
[TBL] [Abstract][Full Text] [Related]
30. Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin?
Prendeville S; Al-Bozom I; Compérat E; Sweet J; Evans AJ; Ben-Gashir M; Mete O; van der Kwast TH; Downes MR
Histopathology; 2017 Dec; 71(6):926-933. PubMed ID: 28756619
[TBL] [Abstract][Full Text] [Related]
31. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic significance of prostatic carcinoma grading according to Helpap].
Mahlke U; Ulman A; Kunz J
Verh Dtsch Ges Pathol; 1993; 77():82-5. PubMed ID: 7511308
[TBL] [Abstract][Full Text] [Related]
33. Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features.
Cohen RJ; Shannon BA; Phillips M; Moorin RE; Wheeler TM; Garrett KL
J Urol; 2008 May; 179(5):1762-7; discussion 1767. PubMed ID: 18343454
[TBL] [Abstract][Full Text] [Related]
34. Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C
Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162
[TBL] [Abstract][Full Text] [Related]
35. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
[TBL] [Abstract][Full Text] [Related]
36. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
37. Improved tissue culture method for the study of prostatic carcinoma: a significant diagnostic tool.
Bologna M; Vicentini C; Muzi P; Festuccia C; Zazzeroni F; di Pasquale B; Valenti M; Corrao G
Pathol Res Pract; 1995 Sep; 191(9):899-903. PubMed ID: 8606871
[TBL] [Abstract][Full Text] [Related]
38. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
Zhou M; Shah R; Shen R; Rubin MA
Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893
[TBL] [Abstract][Full Text] [Related]
39. Stage D1 prostate carcinoma. The histologic appearance of nodal metastases and its relationship to survival.
Brawn P; Kuhl D; Johnson C; Pandya P; McCord R
Cancer; 1990 Feb; 65(3):538-43. PubMed ID: 2297644
[TBL] [Abstract][Full Text] [Related]
40. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
Yu DS; Hsieh DS; Chen HI; Chang SY
J Urol; 2001 Sep; 166(3):871-5. PubMed ID: 11490236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
